The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2025
Journal Information
Statistics
Follow this link to access the full text of the article
Nuevos tratamientos en epoc
Inhibidores de la PDE4: roflumilast
Phosphodiesterase-4 inhibitors: roflumilast
J.L. Izquierdo Alonso
Servicio de Neumología, Hospital Universitario, Guadalajara, España



